Research Papers:

Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth

Lian He, Huijun Yang, Fei Liu, Yiyan Chen, Sijia Tang, Wei Ji, Jianli Tang, Zhudong Liu, Yunjun Sun, Shengbiao Hu, Youming Zhang, Xiong Liu, Weitao Huang, Xuezhi Ding and Liqiu Xia _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:85772-85782. https://doi.org/10.18632/oncotarget.20486

Metrics: PDF 3200 views  |   HTML 5032 views  |   ?  


Lian He1, Huijun Yang1, Fei Liu1, Yiyan Chen1, Sijia Tang1, Wei Ji1, Jianli Tang1, Zhudong Liu1, Yunjun Sun1, Shengbiao Hu1, Youming Zhang1, Xiong Liu1, Weitao Huang1, Xuezhi Ding1 and Liqiu Xia1

1Hunan Provincial Key Laboratory of Microbial Molecular Biology, State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha 410081, Hunan, China

Correspondence to:

Liqiu Xia, email: [email protected]

Keywords: Tum-5, E. coli Nissle 1917, lux operon, anti-angiogenesis, murine melanoma

Received: May 16, 2017     Accepted: July 25, 2017     Published: August 24, 2017


Tumor growth and metastasis depend on angiogenesis. Thus, inhibiting tumor angiogenesis has become promising cancer therapeutic strategy in recent years. Tumstatin is a more powerful angiogenesis inhibitor than endostatin. Anti-angiogenic active fragment encoding amino acids 45–132 (Tum-5) of tumstatin was subcloned into four different inducible expression vectors and successfully solubly expressed in Escherichia coli BL21 (DE3) in this study. Subsequently, an anaerobic inducible expression vector was constructed under Vitreoscilla hemoglobin gene promoter Pvhb in E. coli Nissle 1917 (EcN). The secretory expression of Tum-5 in the engineered bacterium was determined in vitro and in vivo by Western blot or immunochemistry. The anti-tumor effect detection demonstrated that EcN could specifically colonize the tumor, and B16 melanoma tumor growth was remarkably restrained by EcN (Tum-5) in mice bearing B16 melanoma tumor. Abundant infiltrating inflammatory cells were observed in tumor areas of the EcN-treated group through hematoxylin and eosin staining, with a relatively reduced expression of endothelial marker platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) by immunofluorescence in tumor sections of EcN (Tum-5)-treated mice. No significant morphological differences were observed in the liver, kidney and spleen between EcN-treated mice and the control group, indicating that EcN was cleared by the immune system and did not cause systemic toxicity in mice. These findings demonstrated that the gene delivery of Tum-5 to solid tumors could be an effective strategy for cancer therapy.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20486